Skip to main content
OpenTrials

Clinical trial condition

Uterine Carcinosarcoma

Explore clinical trials studying Uterine Carcinosarcoma. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Uterine Carcinosarcoma trial results

Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

NCT05619913

Conditions
Ovarian Carcinosarcoma, Uterine Carcinosarcoma
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Monash Health Clayton, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Completed

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

NCT00478426

Conditions
Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, +5 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 29 locations
View Trial Details
Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

NCT01168232

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • John Muir Medical Center-Concord Campus Concord, California, United States
  • John Muir Medical Center-Walnut Creek Walnut Creek, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
View all 78 locations
View Trial Details
Completed

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

NCT01247571

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details

Related conditions